Compare IPCA Labs with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ALEMBIC PHARMA IPCA LABS/
ALEMBIC PHARMA
 
P/E (TTM) x 22.1 17.6 125.8% View Chart
P/BV x 7.0 6.1 115.4% View Chart
Dividend Yield % 0.2 1.0 24.9%  

Financials

 IPCA LABS   ALEMBIC PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-20
ALEMBIC PHARMA
Mar-20
IPCA LABS/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,616683 236.7%   
Low Rs844435 194.0%   
Sales per share (Unadj.) Rs363.2244.3 148.7%  
Earnings per share (Unadj.) Rs48.442.5 113.9%  
Cash flow per share (Unadj.) Rs65.050.8 128.0%  
Dividends per share (Unadj.) Rs5.0010.00 50.0%  
Dividend yield (eoy) %0.41.8 22.7%  
Book value per share (Unadj.) Rs286.2170.8 167.6%  
Shares outstanding (eoy) m126.35188.52 67.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.42.3 148.1%   
Avg P/E ratio x25.413.2 193.2%  
P/CF ratio (eoy) x18.911.0 172.0%  
Price / Book Value ratio x4.33.3 131.4%  
Dividend payout %10.323.5 43.9%   
Avg Mkt Cap Rs m155,407105,343 147.5%   
No. of employees `000NANA-   
Total wages/salary Rs m9,2129,064 101.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m45,89446,058 99.6%  
Other income Rs m865139 623.2%   
Total revenues Rs m46,75946,196 101.2%   
Gross profit Rs m8,90511,704 76.1%  
Depreciation Rs m2,1051,573 133.8%   
Interest Rs m198272 72.8%   
Profit before tax Rs m7,4679,998 74.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,3531,992 67.9%   
Profit after tax Rs m6,1148,006 76.4%  
Gross profit margin %19.425.4 76.4%  
Effective tax rate %18.119.9 91.0%   
Net profit margin %13.317.4 76.6%  
BALANCE SHEET DATA
Current assets Rs m28,55726,690 107.0%   
Current liabilities Rs m13,26419,578 67.7%   
Net working cap to sales %33.315.4 215.8%  
Current ratio x2.21.4 157.9%  
Inventory Days Days3610 350.8%  
Debtors Days Days77 103.9%  
Net fixed assets Rs m24,02135,263 68.1%   
Share capital Rs m253377 67.0%   
"Free" reserves Rs m35,90331,817 112.8%   
Net worth Rs m36,15532,194 112.3%   
Long term debt Rs m1,0308,870 11.6%   
Total assets Rs m52,57861,953 84.9%  
Interest coverage x38.837.8 102.5%   
Debt to equity ratio x00.3 10.3%  
Sales to assets ratio x0.90.7 117.4%   
Return on assets %12.013.4 89.8%  
Return on equity %16.924.9 68.0%  
Return on capital %20.625.0 82.4%  
Exports to sales %047.3 0.0%   
Imports to sales %013.2 0.0%   
Exports (fob) Rs mNA21,808 0.0%   
Imports (cif) Rs mNA6,062 0.0%   
Fx inflow Rs m21,43821,808 98.3%   
Fx outflow Rs m9,0226,062 148.8%   
Net fx Rs m12,41515,746 78.8%   
CASH FLOW
From Operations Rs m5,6434,492 125.6%  
From Investments Rs m-5,097-7,316 69.7%  
From Financial Activity Rs m-1,3051,549 -84.2%  
Net Cashflow Rs m-755-1,272 59.4%  

Share Holding

Indian Promoters % 46.3 69.0 67.1%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 42.6 17.5 242.8%  
FIIs % 17.5 6.6 266.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 30.5 176.0%  
Shareholders   100,626 99,809 100.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   GODAVARI DRU  DISHMAN CARBOGEN AMCIS  AJANTA PHARMA  JENBURKT PH.  CORAL LAB.  

Compare IPCA LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Maruti Suzuki and UPL Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity today and ended on a flat note.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth(Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Wednesday's Market Fall Explained(Fast Profits Daily)

Jun 10, 2021

This is why the stock market fell the way it did on Wednesday.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jun 22, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS